IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 162 filers reported holding IMMUNOGEN INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $261,855 | -47.6% | 16,500 | -37.7% | 0.03% | -46.4% |
| Q2 2023 | $500,055 | +183.1% | 26,500 | -42.4% | 0.06% | +166.7% |
| Q1 2023 | $176,640 | -22.6% | 46,000 | 0.0% | 0.02% | -27.6% |
| Q4 2022 | $228,160 | +0.5% | 46,000 | -3.2% | 0.03% | -6.5% |
| Q3 2022 | $227,000 | +6.1% | 47,500 | 0.0% | 0.03% | +10.7% |
| Q2 2022 | $214,000 | +5.9% | 47,500 | +11.8% | 0.03% | +16.7% |
| Q1 2022 | $202,000 | -16.2% | 42,500 | +30.8% | 0.02% | -17.2% |
| Q4 2021 | $241,000 | +31.0% | 32,500 | 0.0% | 0.03% | +26.1% |
| Q3 2021 | $184,000 | -5.6% | 32,500 | +9.8% | 0.02% | -11.5% |
| Q2 2021 | $195,000 | -12.6% | 29,600 | +7.6% | 0.03% | -21.2% |
| Q1 2021 | $223,000 | +26.0% | 27,500 | 0.0% | 0.03% | +17.9% |
| Q4 2020 | $177,000 | +293.3% | 27,500 | +120.0% | 0.03% | +250.0% |
| Q3 2020 | $45,000 | -22.4% | 12,500 | 0.0% | 0.01% | -27.3% |
| Q2 2020 | $58,000 | +34.9% | 12,500 | 0.0% | 0.01% | +22.2% |
| Q1 2020 | $43,000 | -32.8% | 12,500 | 0.0% | 0.01% | -25.0% |
| Q4 2019 | $64,000 | +113.3% | 12,500 | 0.0% | 0.01% | +100.0% |
| Q3 2019 | $30,000 | +11.1% | 12,500 | 0.0% | 0.01% | +20.0% |
| Q2 2019 | $27,000 | -20.6% | 12,500 | 0.0% | 0.01% | -44.4% |
| Q1 2019 | $34,000 | -43.3% | 12,500 | 0.0% | 0.01% | -43.8% |
| Q4 2018 | $60,000 | -49.2% | 12,500 | 0.0% | 0.02% | -50.0% |
| Q3 2018 | $118,000 | -3.3% | 12,500 | 0.0% | 0.03% | -8.6% |
| Q2 2018 | $122,000 | -3.9% | 12,500 | 0.0% | 0.04% | -7.9% |
| Q1 2018 | $127,000 | +25.7% | 12,500 | -16.7% | 0.04% | +15.2% |
| Q4 2017 | $101,000 | +1.0% | 15,000 | 0.0% | 0.03% | -2.9% |
| Q3 2017 | $100,000 | -9.1% | 15,000 | 0.0% | 0.03% | -20.9% |
| Q2 2017 | $110,000 | +115.7% | 15,000 | 0.0% | 0.04% | +65.4% |
| Q1 2017 | $51,000 | +41.7% | 15,000 | 0.0% | 0.03% | +18.2% |
| Q4 2016 | $36,000 | – | 15,000 | +23337.5% | 0.02% | – |
| Q2 2016 | $0 | – | 64 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TWIN FOCUS CAPITAL PARTNERS, LLC | 140,000 | $2,090,000 | 2.48% |
| BB BIOTECH AG | 3,165,816 | $47,266,000 | 2.44% |
| SECTORAL ASSET MANAGEMENT INC | 3,623,786 | $54,103,000 | 2.22% |
| Lumbard & Kellner, LLC | 81,225 | $1,192,000 | 1.02% |
| Artal Group S.A. | 1,300,000 | $19,409,000 | 0.70% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 100,000 | $1,493,000 | 0.48% |
| Rhenman & Partners Asset Management AB | 73,702 | $1,100,000 | 0.33% |
| PINNACLE ASSOCIATES LTD | 883,647 | $13,193,000 | 0.26% |
| FIRST TRUST ADVISORS LP | 3,608,918 | $53,881,000 | 0.24% |
| Granahan Investment Management | 540,641 | $8,072,000 | 0.22% |